Author

Polina V. Shnaider

Federal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. LopukhinORCID 0000-0003-2722-6272Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Georgij P. ArapidiiD· 2 shared Aleksandra V. KashinaiD· 1 shared Aleksey M. EmeliniD· 1 shared Anastasia N. KazakovaiD· 1 shared Anna Suzdalenko· 1 shared Anton N. TurchiniD· 1 shared Artem K. VelichkoiD· 1 shared Artem V. LuzhiniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Georgij P. ArapidiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 9, 2025

A trans-acting enhancer lncRNA modulates androgen-dependent gene expression via sequence-specific interaction with the Androgen Receptor

Султанов Ринат Илгизович, Anna Suzdalenko, Polina V. Shnaider…·Georgij P. Arapidi

This paper identifies an enhancer lncRNA that interacts with the Androgen Receptor to regulate gene expression and inhibit prostate cancer cell proliferation.

DOI 10.1101/2025.05.09.652846

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 8, 2023

Unlocking DNA Damage Sensitivity of Cancer Cells: The Potential of Splicing Inhibitors

Ksenia S. Anufrieva, Maria M. Lukina, Olga M. Ivanova…·Victoria О. Shender

This study shows splicing inhibitors induce DNA repair gene downregulation in cancer cells, creating a vulnerability that can be exploited by combining them with DNA-damaging agents.

DOI 10.1101/2023.10.08.561421

humanbulk RNA-seq

𝕏 PostBluesky